KimForest was founded in 2004 in Taiwan. KimForest integrates international and domestic biotech companies that provide devices, reagents, and analysis pipelines to offer advanced genetic testing to healthcare providers, including cancer screening and inherited disease tests. In addition, KimForest is expanding its presence by offering a high-throughput drug screening solution. KimForest has built a comprehensive bioinformatics solution to integrate genomic and clinical data. This high value database can be used for biomarker identification, prognosis prediction, and assisting with early diagnosis. Since 2014, KimForest's Precision Medicine Division has been established to provide next-generation sequencing (NGS) analysis services for cancer studies, including experimental design, sequencing services, bioinformatics analysis, and consulting services.